Read about recent events, essential information and the latest community news.
From the ISCT Exosomes Committee The ISCT Annual Meeting held this year in Vancouver featured a significant event titled "MSC-EVs: Paving the Road to Regulatory Approval," focusing on the potential Read more...
VANCOUVER, British Columbia, July 09, 2024 – The International Society for Cell & Gene Therapy (ISCT) commends the recent verdict in a landmark class action lawsuit against the Lung Institute, a provider Read more...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Dear ISCT membership as we come out of our annual meeting in Vancouver I take over as President and start my regular contributions to Telegraph. Read more...
Tuula Rintala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Barcelona, Spain European Union–Directorate General (DG) organised a SoHO Conference Read more...
by the JSRM-ISCT iPSC Joint Committee JSRM-ISCT iPSC Joint Committee was established in December 2021, aiming to support the dissemination of iPSC-derived cell products as an emerging therapeutic Read more...
by The ISCT Exosomes Committee The ISCT Annual Meeting held this year in Vancouver featured a significant event titled "MSC-EVs: Paving the Road to Regulatory Approval," focusing on the potential Read more...
Olivia Sirpilla Saad Kenderian Mayo Clinic Rochester, MN Disclaimer/Conflict of interest statement. SK is an inventor on patents in the field of CAR immunotherapy that are licensed to Novartis, Read more...
Nisa Renault, PhD Research & Development Associate Director FUJIFILM Cellular Dynamics Madison, Wisconsin, USA The Telegraft Editorial Board is excited to present another live Member Spotlight feature Read more...
Rounak Dubey, MBBS, MD Assistant Professor, Transfusion Medicine All India Institute of Medical Sciences, Nagpur " I know this world is ruled by Infinite Intelligence. It required Infinite Read more...
Author : Aisha Khan, PhD, MBA University of Miami, Miller Scholl of Medicine USA The FDA has recently released a draft guidance document titled “Potency Assurance for Cellular and Gene Therapy Products,” Read more...